Ding Z - Search Results

1

Surgery is a Viable Treatment Option for Stage IE Primary Thyroid Lymphoma.

Tang Y, Yan T, Qiu W, Ding Z, Fan Y, Jiao Q, Yang Z. Tang Y, et al. Among authors: ding z. Ann Surg Oncol. 2024 Feb;31(2):1108-1115. doi: 10.1245/s10434-023-14535-8. Epub 2023 Nov 5. Ann Surg Oncol. 2024. PMID: 37925658

2

Single-port endoscopic thyroidectomy via a submental approach: report of an initial experience.

Ding Z, Deng X, Fan Y, Wu B. Ding Z, et al. Head Neck. 2014 Jul;36(7):E60-4. doi: 10.1002/hed.23213. Epub 2013 Feb 21. Head Neck. 2014. PMID: 23426991

3

Video-assisted selective lateral neck dissection for papillary thyroid carcinoma.

Wu B, Ding Z, Fan Y, Deng X, Guo B, Kang J, Zhong C, Yang Z, Zheng Q. Wu B, et al. Among authors: ding z. Langenbecks Arch Surg. 2013 Mar;398(3):395-401. doi: 10.1007/s00423-012-1045-2. Epub 2013 Jan 10. Langenbecks Arch Surg. 2013. PMID: 23494581

4

Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.

Fan Y, Ding Z, Yang Z, Deng X, Kang J, Wu B, Zheng Q. Fan Y, et al. Among authors: ding z. Mol Med Rep. 2013 Jul;8(1):123-7. doi: 10.3892/mmr.2013.1494. Epub 2013 May 28. Mol Med Rep. 2013. PMID: 23715628

5

FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA.

Ding Z, Ke R, Zhang Y, Fan Y, Fan J. Ding Z, et al. Mol Cell Endocrinol. 2019 Aug 1;493:110420. doi: 10.1016/j.mce.2019.03.010. Epub 2019 May 23. Mol Cell Endocrinol. 2019. PMID: 31129275

6

Transoral endoscopic selective lateral neck dissection for papillary thyroid carcinoma: a pilot study.

Tan Y, Guo B, Deng X, Ding Z, Wu B, Niu Y, Hou J, Zhang Y, Fan Y. Tan Y, et al. Among authors: ding z. Surg Endosc. 2020 Dec;34(12):5274-5282. doi: 10.1007/s00464-019-07314-8. Epub 2019 Dec 13. Surg Endosc. 2020. PMID: 31834511

7

A Novel Multimodal Therapy for Anaplastic Thyroid Carcinoma: ¹²⁵ I Seed Implantation Plus Apatinib After Surgery.

Niu Y, Ding Z, Deng X, Guo B, Kang J, Wu B, Fan Y. Niu Y, et al. Among authors: ding z. Front Endocrinol (Lausanne). 2020 Apr 22;11:207. doi: 10.3389/fendo.2020.00207. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32390940 Free PMC article.

8

Preoperative neoadjuvant targeted therapy with apatinib for inoperable differentiated thyroid cancer: A case report.

Zhang Y, Deng X, Ding Z, Kang J, Wu B, Guo B, Fan Y. Zhang Y, et al. Among authors: ding z. Medicine (Baltimore). 2021 Mar 26;100(12):e25191. doi: 10.1097/MD.0000000000025191. Medicine (Baltimore). 2021. PMID: 33761701 Free PMC article.

9

Corrigendum to "FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA" [Mol. Cell Endocrinol. 493 (2019) 110420 PMID: 31129275].

Ding Z, Ke R, Zhang Y, Fan Y, Fan J. Ding Z, et al. Mol Cell Endocrinol. 2022 Jun 1;549:111640. doi: 10.1016/j.mce.2022.111640. Epub 2022 Apr 9. Mol Cell Endocrinol. 2022. PMID: 35413586 No abstract available.

10

Genetic analysis and clinicopathologic features of locally advanced papillary thyroid cancers: a prospective observational study.

Ding Z, Tao X, Deng X, Guo B, Kang J, Wu B, Yang Z, Chen C, Liu P, Zhang Y, Fan Y, Liu Z. Ding Z, et al. J Cancer Res Clin Oncol. 2023 Aug;149(9):6303-6313. doi: 10.1007/s00432-022-04541-w. Epub 2023 Feb 3. J Cancer Res Clin Oncol. 2023. PMID: 36735028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,440 results

Search Page

Filters